TABLE 1: Executive summary

Executive summary
Target not reached or not in line with other registries
Target attained
Indicator Country average (population)1 Country average (country)1 England Scotland Northern Ireland Wales
Stability: Percentage change (%) for all cancers (C00-C97 ex. C44) in 2018 compared with 2015-2017 4.1% 3.8% 4.1% 4.6% 2.3% 4.1%
Registry Creep: Percentage (%) for all cancers (C00-C97 ex. C44) of 2017 registrations (extracted between 31/12/19 and 20/04/2020) compared with registrations extracted between 02/02/2019 and 01/03/20196. 1.3% 1.6% 1.2% 1.9% 2.8% 0.3%
Staging: Proportion (%) of all cases (C00-C97 ex. C44) with valid known stage registered out of all 2018 registered cancers (C00-C97 ex. C44)2 79.9% 77.2% 81.3% 67.6% 80.4% 79.6%
Average of Core Patient Information Complete: Average percentage (%) of all cancers (C00-C97 ex. C44) registered with demographic information3 98.6% 96.9% 99.2% 96.3% 100.0% 92.0%
Average of Core Tumour Information Complete: Average percentage (%) of all cancers (C00-C97 ex. C44) registered with tumour information4 97.3% 96.9% 97.5% 96.4% 96.7% 97.1%
Diagnosing Hospital Known: Percentage (%) of all cancers (C00-C97 ex. C44) registered with an organisation of diagnosis 97.9% 96.7% 98.3% 94.1% - 97.7%
Death Certificate Only (DCO) Rates: Percentage (%) of all cancers (C00-C97 ex. C44) registered as a DCO5 0.6% 0.6% 0.6% 0.2% 0.3% 1.2%
Zero Day Survivors: Percentage (%) of all cancers (C00-C97 ex. C44) registered with the date of death equals the date of diagnosis5 1.2% 1.0% 1.2% 0.5% 0.5% 1.9%
Microscopically Verified: Percentage (%) of all cancers (C00-C97 ex. C44) that are microscopically verified 84.8% 84.3% 85.1% 82.4% 85.7% 84.1%
Non Specific Codes: Percentage (%) of all cancers (C00-C97 ex. C44) that are microscopically verified with non specific morphology codes 1.2% 1.1% 1.2% 0.9% 1.6% 0.7%
Grade: Percentage (%) of all cancers (C00-C97 ex. C44) registered with a known grade 60.0% 60.9% 59.9% 59.7% 63.0% 60.9%
Treatment: Percentage (%) of all cancers (C00-C97 ex. C44) registered with any treatment 88.2% 85.6% 88.8% 85.6% - 82.5%
Breast Screening Data: Percentage of breast cancer (C50) cases from 2017 screen detected for ages 50-64 49.1% 51.3% 48.7% 50.1% - 55.1%
Cervical Screening Data: Percentage of cervical cancer (C53) cases from 2017 screen detected for ages 25-60 23.6% 23.8% 22.1% 49.3% - 0.0%
Bowel Screening Data: Percentage of bowel cancer (C18-C20) cases from 2017 screen detected for ages 60-69 4.3% 19.0% 0.0% 29.4% - 27.5%
  1. For England, Scotland, Wales and Northern Ireland.
  2. Staging target: > 70%
  3. Core Patient information includes name, address, postcode, sex, date of birth, ethnicity, date of death, unique health identifier
  4. Core Tumour information includes date of diagnosis, site of primary growth, type of growth, behaviour of growth, basis of diagnosis, hospital of diagnosis
  5. DCO and zero survivor rate targets: <2%
  6. Extraction dates for last years indicators: England & Wales 02/02/2019, Scotland 01/03/2019 & Northern Ireland 28/02/2019
  • Extraction dates for this years indicators: England 04/04/2020, Scotland 20/04/2020, Northern Ireland 31/01/2020 & Wales 31/12/2019
Notation '-' denotes not available (average excludes corresponding country)